XML 14 R5.htm IDEA: XBRL DOCUMENT v3.23.3
Consolidated Statements of Cash Flows - USD ($)
9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
OPERATING ACTIVITIES:    
Net loss $ (19,948,158) $ (18,136,164)
Adjustments to reconciled net loss to net cash used by operating activities:    
Depreciation of property, plant, and equipment 32,378 39,141
Amortization of intangible assets 1,496,955 3,044,395
Changes in operating assets and liabilities:    
Accounts receivable 1,054,309 1,010,137
Prepayments, deposit and other receivables 137,367 99,428
Accounts payable (2,129,577) 1,488,965
Accruals 383,963 1,486,482
Operating lease 41,533 0
Deferred revenue 0 (9,795)
Net cash (used in) operating activities (18,931,230) (10,977,411)
INVESTING ACTIVITIES:    
Amount due from associate 0 7,208,700
Amount due from related party (482,420) 0
Financial assets held for resale 0 681
Net cash provided by (used in) investing activities (482,420) 7,209,381
FINANCING ACTIVITIES:    
Proceeds from shares to be issued (260,220) (212,778)
Issuance of shares for services and cash received, net of expenses 19,594,517 2,782,821
Net cash provided by (used in) financing activities 19,334,297 2,570,043
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS (79,353) (1,197,987)
CASH AND CASH EQUIVALENTS AND RESTRICTED CASH, BEGINNING OF PERIOD 472,206 1,586,265
CASH AND CASH EQUIVALENTS AND RESTRICTED CASH, END OF PERIOD 392,853 388,278
NON-CASH TRANSACTION    
Issuance of shares for services received $ 14,135,579 $ 5,969,804